Emergency Potassium Normalization Treatment Including Sodium Zirconium Cyclosilicate: A Phase II, Randomized, Double‐blind, Placebo‐controlled Study (ENERGIZE)

OBJECTIVES: Sodium zirconium cyclosilicate (SZC) is a novel, highly selective potassium binder currently approved in the United States and European Union for treatment of hyperkalemia. This pilot evaluation explored the efficacy of SZC with insulin and glucose as hyperkalemia treatment in the emerge...

Descripción completa

Detalles Bibliográficos
Autores principales: Peacock, W. Frank, Rafique, Zubaid, Vishnevskiy, Konstantin, Michelson, Edward, Vishneva, Elena, Zvereva, Tatiana, Nahra, Rajaa, Li, Dao, Miller, Joseph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Contributions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318712/
https://www.ncbi.nlm.nih.gov/pubmed/32149451
http://dx.doi.org/10.1111/acem.13954

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318712/
https://www.ncbi.nlm.nih.gov/pubmed/32149451
http://dx.doi.org/10.1111/acem.13954

Ejemplares similares